ArticleScientific reports2025
Rapid thrombogenesis prediction in COVID-19 patients using DNN with data labeling.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The rapid spread of COVID-19 globally has led to a surge in patients, among whom the incidence of blood clotting has been observed. This phenomenon poses a significant risk, potentially leading to cerebral hemorrhage and severe complications. Early detection of such blood clotting events is crucial for timely intervention and management of secondary complications. Computational Fluid Dynamics (CFD) simulations offer a means to detect these clotting phenomena, albeit with a drawback of time-intensive confirmation, spanning from several days to months. To address this challenge, we propose a framework for early detection of blood clotting events utilizing a deep neural network model. Leveraging patient-specific data derived from CFD simulations, our model learns to predict clotting events, expediting the diagnostic process. Hyperparameter tuning was employed to optimize the deep neural network algorithm for enhanced accuracy and performance. Furthermore, our framework facilitated comparative simulations across various machine learning algorithms, aiding in the identification of optimal data sizes for achieving high predictive accuracy. By combining computational modeling with machine learning techniques, our approach offers a promising avenue for expedited detection and management of thrombogenesis phenomena in COVID-19 patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.